Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ret proto-oncogene | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0081 | 0.3409 | 0.32 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.3552 | 0.3348 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0149 | 1 | 1 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.0083 | 0.3552 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0081 | 0.3409 | 0.32 |
Brugia malayi | hypothetical protein | 0.0083 | 0.3552 | 0.3348 |
Entamoeba histolytica | nucleoside transporter, putative | 0.0083 | 0.3552 | 0.5 |
Echinococcus granulosus | equilibrative nucleoside transporter 3 | 0.0083 | 0.3552 | 0.3348 |
Giardia lamblia | Hypothetical protein | 0.0083 | 0.3552 | 0.5 |
Brugia malayi | Nucleoside transporter family protein | 0.0083 | 0.3552 | 0.3348 |
Schistosoma mansoni | tyrosine kinase | 0.0081 | 0.3409 | 0.32 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.3164 | 0.2947 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0081 | 0.3409 | 0.3409 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0149 | 1 | 1 |
Echinococcus multilocularis | equilibrative nucleoside transporter 3 | 0.0083 | 0.3552 | 0.3552 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0149 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.3552 | 0.3348 |
Echinococcus granulosus | equilibrative nucleoside transporter | 0.0083 | 0.3552 | 0.3348 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.0083 | 0.3552 | 0.5 |
Echinococcus multilocularis | insulin receptor | 0.0049 | 0.0307 | 0.0307 |
Echinococcus multilocularis | equilibrative nucleoside transporter protein | 0.0083 | 0.3552 | 0.3552 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.3164 | 0.2947 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.3164 | 0.2947 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.0083 | 0.3552 | 0.5 |
Onchocerca volvulus | Equilibrative nucleoside transporter, putative homolog | 0.0083 | 0.3552 | 0.5 |
Onchocerca volvulus | Equilibrative nucleoside transporter, putative homolog | 0.0083 | 0.3552 | 0.5 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0049 | 0.0307 | 0.0307 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.3552 | 0.3348 |
Schistosoma mansoni | tyrosine kinase | 0.0149 | 1 | 1 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.0083 | 0.3552 | 0.5 |
Echinococcus multilocularis | equilibrative nucleoside transporter 3 | 0.0068 | 0.2169 | 0.2169 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0081 | 0.3409 | 0.32 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Inhibitory of lyn | ChEMBL. | 17884497 | |
Activity (binding) | Inhibitory of VEGFR2 | ChEMBL. | 17884497 | |
Activity (binding) | Inhibitory of c-SRC | ChEMBL. | 17884497 | |
Activity (binding) | Inhibitory of TIE2 | ChEMBL. | 17884497 | |
Activity (binding) | 0 | Inhibitory of c-SRC | ChEMBL. | 17884497 |
Activity (binding) | 0 | Inhibitory of lyn | ChEMBL. | 17884497 |
Activity (binding) | 0 | Inhibitory of VEGFR2 | ChEMBL. | 17884497 |
Activity (binding) | 0 | Inhibitory of TIE2 | ChEMBL. | 17884497 |
ED50 (binding) | = 45 nM | Inhibition of chimeric human EGFR/RET kinase expressed in SK-N-MC cells after 1 hr by western blotting | ChEMBL. | 17884497 |
IC50 (binding) | = 34 nM | Inhibition of RET kinase in Sf9 cells | ChEMBL. | 17884497 |
IC50 (binding) | = 34 nM | Inhibition of RET kinase in Sf9 cells | ChEMBL. | 17884497 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.